A new meta-analysis examined four studies covering almost 120,000 patients and found a higher rate of C. diff among people taking opioids. About 31% of patients on opioids developed C. diff, compared with 17% of patients who were not using opioids. The team notes that people taking certain antibiotics or those with weakened immune systems are already at higher risk; opioid use could be an additional factor.
Past research cited in the paper suggests two possible mechanisms. Opioids can suppress the immune response that fights infections and they can disrupt the balance of healthy gut bacteria. Healthy gut bacteria help defend against pathogens such as C. diff.
Coauthor Lorenzo Villa-Zapata said evidence is mixed, and lead author Pooja Gokhale noted that opioids can "mess with the gut microbiome" and increase susceptibility. The researchers recommend that physicians weigh benefits and side effects and make case-by-case decisions.
Difficult words
- meta-analysis — Study that combines results from several studies
- opioid — Drug used to reduce severe painopioids
- antibiotic — Medicine that kills or stops bacteria growthantibiotics
- immune system — Body's organs and cells that fight infectionimmune systems
- microbiome — All the microorganisms living in one body area
- susceptibility — How likely someone is to get an illness
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you think doctors should change how they prescribe opioids because of this study? Why or why not?
- If you needed strong pain medicine, what questions would you ask your doctor about risks like C. diff?
- What steps can hospitals take to protect patients who need opioids from infections?
Related articles
Experimental vaccine gives lasting protection in mice against CCHF
A new mouse study reports an experimental vaccine that produced rapid protection and antibodies that lasted up to 18 months. Researchers say a booster strengthened and extended immune responses and plan manufacturing steps before human trials.
Engineered antibodies could block cytomegalovirus
A research team created changed antibodies that stop human cytomegalovirus from disabling immune responses. Lab tests show the antibodies reduce virus spread, but researchers say more testing is needed before they can be used in people.
Exercise helps reduce 'chemo brain' during chemotherapy
Researchers tested a home exercise program during chemotherapy and found patients who followed it kept daily activity and reported clearer thinking. The trial compared a six-week exercise plan with standard care during treatment.